DNA demethylation in the PTEN gene promoter induced by 5-azacytidine activates PTEN expression in the MG-63 human osteosarcoma cell line

Experimental and Therapeutic Medicine

Volumn 7, Issue 5, 2014, Pages 1071-1076

  Song, Deye ^a   Ni, Jiangdong ^a   Xie, Hongming ^a   Ding, Muliang ^a   Wang, Jun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

5 azacytidine; DNA demethylation; MG 63 human osteosarcoma cell line; PTEN expression; PTEN gene

Indexed keywords

AZACITIDINE; MESSENGER RNA; MYC PROTEIN; TRANSCRIPTION FACTOR SP1;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DEMETHYLATION; DNA DEMETHYLATION; DNA EXTRACTION; DNA METHYLATION; DNA SEQUENCE; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOSARCOMA; PHOSPHATE AND TENSION HOMOLOG GENE; PROMOTER REGION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET SPECTROPHOTOMETRY; WESTERN BLOTTING;

EID: 84896889340     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1571     Document Type: Article

References (18)

1. Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 115: 1531-1543, 2009.
2. Bielack SS and Carrle D: State-of-the-art approach in selective curable tumors: bone sarcoma. Ann Oncol 19 (Suppl 7): vii155-vii160, 2008.
3. Picci P, Mercuri M, Ferrari S, etal: Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol 21: 1366-1373, 2010.
4. Yim EK, Peng G, Dai H, etal: Rak functions as a tumor suppressor by regulating PTEN protein stability and function. Cancer Cell 15: 304-314, 2009.
5. Song MS, Carracedo A, Salmena L, etal: Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 144: 187-199, 2011.
6. Li L, Ernsting BR, Wishart MJ, Lohse DL and Dixon JE: A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast. J Biol Chem 272: 29403-29406, 1997.
7. Yu J, Zhang SS, Saito K, etal: PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J 28: 21-33, 2009.
8. Tamura M, Gu J, Danen EH, etal: PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 274: 20693-20703, 1999.
9. Chung JH, Ostrowski MC, Romigh T, etal: The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum Mol Genet 15: 2553-2559, 2006.
10. Huang T, Sun J, Lu G, etal: Expression and significance of PTEN in osteosarcoma. J Chin Med Univ33: 245-246, 2004.
11. Nielsen-Preiss SM, Silva SR and Gillette JM: Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells. J Cell Biochem 90: 964-975, 2003.
12. Tsumura A, Hayakawa T, Kumaki Y, etal: Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmtl, Dnmt3a and Dnmt3b. Genes Cells 11: 805-814, 2006.
13. Polanowska J, Martin JS, Garcia-Muse T, etal: A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites. EMBO J 25: 2178-2188, 2006.
14. Hashemi M, Rezaei H, Eskandari-Nasab E, Kaykhaei MA and Taheri M: Association of promoter methylation and 32-bp deletion of the PTEN gene with susceptibility to metabolic syndrome. Mol Med Rep 7: 342-346, 2013.
15. Lubecka-Pietruszewska K, Kaufman-Szymczyk A, Stefanska B and Fabianowska-Majewska K: Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer. Biochem Biophys Res Commun 430: 623-628, 2013.
16. Bian EB, Huang C, Ma TT, Tao H, Zhang H, Cheng C, Lv XW and Li J: DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol 264: 13-22, 2012.
17. Kou XX, Hao T, Meng Z, Zhou YH and Gan YH: Acetylated Sp1 inhibits PTEN expression through binding to PTEN core promoter and recruitment of HDAC1 and promotes cancer cell migration and invasion. Carcinogenesis 34: 58-67, 2013.
18. Peyrou M, Bourgoin L and Foti M: PTEN in liver diseases and cancer. World J Gastroenterol 16: 4627-4633, 2010.